ID   BRB1_MOUSE     STANDARD;      PRT;   334 AA.
AC   Q61125; Q9Z1F4;
DT   16-OCT-2001 (Rel. 40, Created)
DT   16-OCT-2001 (Rel. 40, Last sequence update)
DT   16-OCT-2001 (Rel. 40, Last annotation update)
DE   B1 bradykinin receptor (BK-1 receptor) (B1R).
GN   BDKRB1 OR BDKRB.
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Rodentia; Sciurognathi; Muridae; Murinae; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   SEQUENCE FROM N.A., AND INDUCTION.
RC   STRAIN=129/SvJ;
RX   MEDLINE=96176983; PubMed=8602848;
RA   Pesquero J.B., Pesquero J.L., Oliveira S.M., Roscher A.A., Metzger R.,
RA   Ganten D., Bader M.;
RT   "Molecular cloning and functional characterization of a mouse
RT   bradykinin B1 receptor gene.";
RL   Biochem. Biophys. Res. Commun. 220:219-225(1996).
RN   [2]
RP   SEQUENCE FROM N.A.
RA   Yanagawa T., Prado G.N., Paquet J.L., Bestian S., Cousins B.,
RA   Navarro J.;
RT   "Novel pharmacological selectivity of the cloned murine B1 bradykinin
RT   receptor.";
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: THIS IS A RECEPTOR FOR BRADYKININ. COULD BE A FACTOR IN
CC       CHRONIC PAIN AND INFLAMMATION.
CC   -!- SUBCELLULAR LOCATION: Integral membrane protein.
CC   -!- TISSUE SPECIFICITY: EXPRESSED IN HEART, LIVER AND LUNG.
CC   -!- INDUCTION: BY LIPOPOLYSACCHARIDE (LPS) IN HEART, LIVER AND LUNG
CC       FIVE HOURS AFTER TREATMENT.
CC   -!- SIMILARITY: BELONGS TO FAMILY 1 OF G-PROTEIN COUPLED RECEPTORS.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U47281; AAA99778.1; -.
DR   EMBL; U44436; AAD00029.1; -.
DR   MGD; MGI:88144; Bdkrb.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; FALSE_NEG.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
KW   G-protein coupled receptor; Transmembrane; Glycoprotein.
FT   DOMAIN        1     41       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM     42     62       1 (POTENTIAL).
FT   DOMAIN       63     80       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM     81    101       2 (POTENTIAL).
FT   DOMAIN      102    118       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    119    139       3 (POTENTIAL).
FT   DOMAIN      140    161       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    162    182       4 (POTENTIAL).
FT   DOMAIN      183    214       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    215    235       5 (POTENTIAL).
FT   DOMAIN      236    258       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    259    279       6 (POTENTIAL).
FT   DOMAIN      280    302       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    303    323       7 (POTENTIAL).
FT   DOMAIN      324    334       CYTOPLASMIC (POTENTIAL).
FT   DISULFID    117    196       BY SIMILARITY.
FT   CARBOHYD     13     13       N-LINKED (GLCNAC...) (POTENTIAL).
FT   CARBOHYD     21     21       N-LINKED (GLCNAC...) (POTENTIAL).
FT   CARBOHYD    192    192       N-LINKED (GLCNAC...) (POTENTIAL).
FT   CONFLICT    216    216       L -> V (IN REF. 2).
FT   CONFLICT    260    260       L -> P (IN REF. 2).
FT   CONFLICT    263    265       VAS -> SSL (IN REF. 2).
FT   CONFLICT    331    334       LGTL -> WELYKRCTSLKNAVLPSRKELFQLSCWN (IN
FT                                REF. 2).
SQ   SEQUENCE   334 AA;  37885 MW;  77C806203AC5C6CC CRC64;
     MASQASLKLQ PSNQSQQAPP NITSCEGAPE AWDLLCRVLP GFVITVCFFG LLGNLLVLSF
     FLLPWRRWWQ QRRQRLTIAE IYLANLAASD LVFVLGLPFW AENVGNRFNW PFGSDLCRVV
     SGVIKANLFI SIFLVVAISQ DRYRLLVYPM TSWGNRRRRQ AQVTCLLIWV AGGLLSTPTF
     LLRSVKVVPD LNISACILLF PHEAWHFVRM VELNVLGFLL PLAAILYFNF HILASLRGQK
     EASRTRCGGP KDSKTMGLIL TLVASFLVCW APYHFFAFLD FLVQVRVIQD CFWKELTDLG
     LQLANFFAFV NSCLNPLIYV FAGRLFKTRV LGTL
//